Reading room

Terapia June 2021 NR 6 ( 401 )

Hypertension and lipid disorders

Editor of the issue: prof. dr hab. n. med. Andrzej Januszewicz, prof. dr hab. n. med. Aleksander Prejbisz, dr hab. n. med. Piotr Dobrowolski, prof. inst.

Contents:

Hyperkalemia in patients with arterial hypertension

    Authors:
  • lek. Stanisław Surma
  • prof. dr hab. n. med. Andrzej Więcek
  • prof. dr hab. n. med. Marcin Adamczak
Keywords: hyperkalemia, arterial hypertension, chronic kidney disease

One pandemic wave after another, and atherosclerosis is progressing

    Authors:
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: lipid disorders, COVID-19, statins

Progression of atherosclerosis ‒ it is important to control both hypertension and hypercholesterolemia

    Authors:
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: hypertension, hypercholesterolemia, treatment

From left ventricular hypertrophy to heart failure ‒ the importance of blood pressure control

    Authors:
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: hypertension, left ventricular hypertrophy, heart failure, treatment strategy

Can optimal treatment of arterial hypertension interfere with the unfavorable relation between arterial stiffness and the development of stroke?

    Authors:
  • prof. dr hab. n. med. Andrzej Januszewicz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
Keywords: hypertension, arterial stiffness, aging, treatment

Lacidipine in modern therapy of arterial hypertension and comorbidities

    Authors:
  • prof. dr hab. n. med. Adrian Doroszko
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
Keywords: dihydropiridine calcium channel blockers, lacidipine, hypertension, chronic coronary syndrome

β-blockers in the treatment of arterial hypertension ‒ optimal choice in particular clinical settings

    Authors:
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: nadciśnienie tętnicze, leczenie, β-adrenolityki

Combined treatment with an angiotensin II receptor antagonist and a thiazide diuretic, as exemplified by telmisartan and hydrochlorothiazide

    Authors:
  • prof. dr hab. n. med. Andrzej Januszewicz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
Keywords: hypertension, telmisartan, hydrochlorothiazide, combination therapy

PCSK9 inhibitors in patients with very high cardiovascular risk ‒ a new treatment option not only in familial hypercholesterolemia

    Authors:
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: hypercholesterolaemia, high/very high cardiovascular risk, PCSK9 inhibitors